One of the challenges faced by BIOIBERICA S.A. during its planned expansion is the entrance in the sector of the ethical pharmaceutical specialties

We have currently two products being registered with the ministry that will be an important innovation in the Spanish market.

Both products can be classified among products addressing all diseases related to the locomotive system such as arthritis, arthrosis, and others.

The objective of BIOIBERICA S.A is to achieve a leading position in the market sector of the so called Chondrocyte protectors.